No Data
Shenzhen Leaguer (002243.SZ): Continuously extending to the early stage of innovation chain through concept verification fund and pilot fund.
On November 21st, Shenzhen Leaguer (002243.SZ) stated at the investor relations event that this year, the company reinforced its strategy of investing in and incubating businesses with a focus on 'earlier, smaller, and more technology-driven' initiatives. The company further concentrated on the transformation of technology achievements, investing in enterprises such as Precision Medical Devices, Putai Technology, and Hesi Technology, covering areas of hard technology such as MRI-guided surgical robots, calcium titanium batteries, and aoi inspection equipment; extensively engaging in strategic cooperation with key higher education institutions, research institutes, and emerging R&D institutions, signing a strategic cooperation agreement with the Hong Kong University of Science and Technology (Guangzhou) for technology transfer, and transferring technology from South China University of Technology and Shenzhen University.
Subdued Growth No Barrier To Shenzhen Leaguer Co., Ltd. (SZSE:002243) With Shares Advancing 32%
Shenzhen Leaguer (002243.SZ): Microling Medical mainly engages in the research and development of medical-grade fully implantable wireless brain-computer interface systems.
Gelonghui November 12th | Shenzhen Leaguer (002243.SZ) stated on the investor interaction platform that the company has invested in and incubated Shenzhen Weiling Medical Technology Co., Ltd in the brain-computer interface field. Weiling Medical is mainly engaged in the research and development of medical-grade fully implanted wireless brain-computer interface systems. In 2023, the company completed two rounds of follow-up financing, with a total financing amount exceeding 70 million yuan.
Why Shenzhen Leaguer's (SZSE:002243) Soft Earnings Are Just The Beginning Of Its Problems
Shenzhen's "venture capital nineteen measures" are officially released! Leading the development of "bold capital", Shenzhen Leaguer (002243.SZ) undertakes the mission of scientific and technological innovation service.
On October 25th, the A-shares Shenzhen sector opened strong, with Shenzhen Leaguer, Konka Group Co., Ltd, Shenzhen Huakong Seg and others hitting the limit up, attracting the attention of many investors. This is directly related to a major bullish news released by Shenzhen. On the 24th, Shenzhen issued the "Action Plan for Promoting the High-Quality Development of Venture Capital in Shenzhen (2024-2026) (Draft for Public Consultation)" (hereinafter referred to as the Action Plan), which for the first time nationwide proposed the term "bold capital". The document focuses on leading the development of "bold capital", cultivating "patient capital", attracting "overseas capital", strengthening "industrial capital", and optimizing and enhancing the venture capital industry.
Lihe Kechuang: Report for the third quarter of 2024
Improved Earnings Required Before Shenzhen Leaguer Co., Ltd. (SZSE:002243) Stock's 36% Jump Looks JustifiedNo Data
No Data
